Facioscapulohumeral muscular dystrophy and DUX4: Breaking the silence

Trends in Molecular Medicine

Volumn 17, Issue 5, 2011, Pages 252-258

  Van der Maarel, Silvère M ^a   Tawil, Rabi ^b   Tapscott, Stephen J ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE HOMEOBOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ALLELE; CHROMATIN; CHROMOSOME 4Q; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENETIC POLYMORPHISM; HUMAN; MUSCLE CELL; PROTEIN EXPRESSION; REVIEW; SATELLITE CELL; SOMATIC CELL; TELOMERE;

CHROMATIN; EPIGENOMICS; GENE SILENCING; HOMEODOMAIN PROTEINS; HUMANS; MICROSATELLITE REPEATS; MODELS, GENETIC; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; TRANSCRIPTION, GENETIC;

EID: 79955664112     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2011.01.001     Document Type: Review

References (52)

1. Pandya S., et al. Facioscapulohumeral dystrophy. Phys. Ther. 2008, 88:105-113.
2. Tawil R., van der Maarel S.M. Facioscapulohumeral muscular dystrophy. Muscle Nerve 2006, 34:1-15.
3. Wijmenga C., et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat. Genet. 1992, 2:26-30.
4. Wijmenga C., et al. Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet 1990, 336:651-653.
5. van Deutekom J.C., et al. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2kb tandemly repeated unit. Hum. Mol. Genet. 1993, 2:2037-2042.
6. de Greef J.C., et al. Epigenetic mechanisms of facioscapulohumeral muscular dystrophy. Mutat. Res. 2008, 647:94-102.
7. van Deutekom J.C., et al. Evidence for subtelomeric exchange of 3.3kb tandemly repeated units between chromosomes 4q35 and 10q26: implications for genetic counselling and etiology of FSHD1. Hum. Mol. Genet. 1996, 5:1997-2003.
8. Tupler R., et al. Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy. J. Med. Genet. 1996, 33:366-370.
9. Lemmers R.J., et al. Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy. Am. J. Hum. Genet. 2007, 81:884-894.
10. Bakker E., et al. The FSHD-linked locus D4F104S1 (p13E-11) on 4q35 has a homologue on 10qter. Muscle Nerve 1995, 2:39-44.
11. Deidda G., et al. Physical mapping evidence for a duplicated region on chromosome 10qter showing high homology with the facioscapulohumeral muscular dystrophy locus on chromosome 4qter. Eur. J. Hum. Genet. 1995, 3:155-167.
12. Lemmers R.J., et al. Inter- and intrachromosomal subtelomeric rearrangements on 4q35: implications for facioscapulohumeral muscular dystrophy (FSHD) aetiology and diagnosis. Hum. Mol. Genet. 1998, 7:1207-1214.
13. van Overveld P.G., et al. Interchromosomal repeat array interactions between chromosomes 4 and 10: a model for subtelomeric plasticity. Hum. Mol. Genet. 2000, 9:2879-2884.
14. Lemmers R.J., et al. Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis. Ann. Neurol. 2001, 50:816-819.
15. Zhang Y., et al. Improved characterization of FSHD mutations. Ann. Genet. 2001, 44:105-110.
16. Gabellini, D. et al. (2002) Inappropriate gene activation in FSHD. A repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 110, 339-348.
17. Jiang G., et al. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Hum. Mol. Genet. 2003, 12:2909-2921.
18. Bodega B., et al. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation. BMC Biol. 2009, 7:41.
19. Dmitriev P., et al. Pearls in the junk: dissecting the molecular pathogenesis of facioscapulohumeral muscular dystrophy. Neuromuscul. Disord. 2009, 19:17-20.
20. Mefford H.C., Trask B.J. The complex structure and dynamic evolution of human subtelomeres. Nat. Rev. Genet. 2002, 3:91-102.
21. van Geel M., et al. Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin. Genomics 2002, 79:210-217.
22. Lemmers R.J., et al. Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere. Nat. Genet. 2002, 32:235-236.
23. Lemmers R.J., et al. Mechanism and timing of mitotic rearrangements in the subtelomeric D4Z4 repeat involved in facioscapulohumeral muscular dystrophy. Am. J. Hum. Genet. 2004, 75:44-53.
24. Thomas N.S., et al. A large patient study confirming that facioscapulohumeral muscular dystrophy (FSHD) disease expression is almost exclusively associated with an FSHD locus located on a 4qA-defined 4qter subtelomere. J. Med. Genet. 2007, 44:215-218.
25. Wang, Z.Q. et al. (2011) Distinguishing the 4qA and 4qB variants is essential for the diagnosis of facioscapulohumeral muscular dystrophy in the Chinese population. Eur. J. Hum. Genet. 19, 64-69.
26. Lemmers R.J., et al. Worldwide population analysis of the 4q and 10q subtelomeres identifies only four discrete duplication events in human evolution. Am. J. Hum. Genet. 2010, 86:364-377.
27. Spurlock G., et al. Confirmation that the specific SSLP microsatellite allele 4qA161 segregates with fascioscapulohumeral muscular dystrophy (FSHD) in a cohort of multiplex and simplex FSHD families. Muscle Nerve 2010, 42:820-821.
28. Lemmers R.J., et al. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 2010, 329:1650-1653.
29. Hewitt J.E., et al. Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum. Mol. Genet. 1994, 3:1287-1295.
30. Gabriels J., et al. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3kb element. Gene 1999, 236:25-32.
31. Clapp J., et al. Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy. Am. J. Hum. Genet. 2007, 81:264-279.
32. Wu S.L., et al. Characterization of genomic structures and expression profiles of three tandem repeats of a mouse double homeobox gene: Duxbl. Dev. Dyn. 2010, 239:927-940.
33. Leidenroth A., Hewitt J.E. A family history of DUX4: phylogenetic analysis of DUXA, B, C and Duxbl reveals the ancestral DUX gene. BMC Evol. Biol. 2010, 10:364.
34. Snider L., et al. RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. Hum. Mol. Genet. 2009, 18:2414-2430.
35. Dixit M., et al. DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:18157-18162.
36. Kowaljow V., et al. The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul. Disord. 2007, 17:611-623.
37. Bosnakovski D., et al. An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J. 2008, 27:2766-2779.
38. Bosnakovski D., et al. Biphasic myopathic phenotype of mouse DUX, an ORF within conserved FSHD-related repeats. PLoS ONE 2009, 4:e7003.
39. Wuebbles R.D., et al. Testing the effects of FSHD candidate gene expression in vertebrate muscle development. Int. J. Clin. Exp. Pathol. 2010, 3:386-400.
40. Lyle R., et al. The FSHD-associated repeat, D4Z4, is a member of a dispersed family of homeobox-containing repeats, subsets of which are clustered on the short arms of the acrocentric chromosomes. Genomics 1995, 28:389-397.
41. van Overveld P.G., et al. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat. Genet. 2003, 35:315-317.
42. Zeng W., et al. Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). PLoS Genet. 2009, 5:e1000559.
43. Ottaviani A., et al. Identification of a perinuclear positioning element in human subtelomeres that requires A-type lamins and CTCF. EMBO J. 2009, 28:2428-2436.
44. de Greef J.C., et al. Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD. Hum. Mutat. 2009, 30:1449-1459.
45. de Greef, J.C. et al. (2010) Clinical features of facioscapulohumeral muscular dystrophy 2. Neurology 75, 1548-1554.
46. de Greef J.C., et al. Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD. Neurology 2007, 69:1018-1026.
47. Snider, L. et al. (2010) Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet. 6:e1001181.
48. Padberg, G.W. (1982) Facioscapulohumeral disease. Thesis, Leiden University.
49. Fitzsimons R.B., et al. Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. Brain 1987, 110:631-648.
50. Padberg G.W., et al. On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy. Muscle Nerve 1995, 2:S73-S80.
51. Lunt P.W., et al. Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD). Hum. Mol. Genet. 1995, 4:951-958.
52. Wilbers J., et al. Facioscapulohumerale spierdystrofie. Ned Tijdschr Tandheelkd 2010, 117:11-14.